Romanian health ministry responds after being sued by patients

Published: 2-Jul-2014
Regulatory

Will publish a revised list of medicines for cancer and chronic diseases


The Romanian health ministry is working on the revised list of medicines that patients suffering from cancer and other chronic disease could receive under their healthcare coverage in the country, after it was sued by patients’ organisations in May.

The country’s Association of Cancer Patients sued the ministry, the Romanian government and the national health insurance organisation for failing to update, over the past six years, the list of medicines for cancer and other chronic diseases covered by healthcare benefits. According to the association, about 1,000 Romanian patients do not have access to the medicines they need.

'We are being sacrificed in the name of the crisis; adults and children who have real chances of survival keep dying and no one in Romania is responsible for these deaths,' an Association spokesperson said.

See more

You may also like

Manufacturing

Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success

Read more
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for successful market entry from the early stages of development, reports Frederick Duynslaeger, Senior CMC Writer at Ardena

Trending Articles

  1. Isospec Analytics launches biomolecular analysis technology to identify unknown molecules The novel technology optimises the identification process of unknown molecules compared to mass analysis
  2. 4SC AG receives Paediatric Investigation Plan waiver for resminostat from the UK MHRA The waiver allows the company to avoid investigating the CTCL drug in a paediatric population, as it's considered unnecessary or inappropriate for use by this patient group
  3. Scleroderma treatment by Certa Therapeutics granted US FDA fast track FT011 is a novel, first-in-class oral therapy for the treatment of chronic fibrosis in multiple organs
  4. Ametek Mocon achieves accreditation for analytical testing laboratory Ametek Mocon, provider of instruments and services for testing, measuring and analysing a variety of gases, has achieved ISO/IEC 17025 accreditation for its Minneapolis analytical testing laboratory
  5. Highly potent APIs: Hazards in classification and handling This variability and subjective nature of classification means that the OEL is best considered as a tool for site risk management teams

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

You may also like

Manufacturing

Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success

Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for successful market entry from the early stages of development, reports Frederick Duynslaeger, Senior CMC Writer at Ardena
Regulatory

Isospec Analytics launches biomolecular analysis technology to identify unknown molecules

The novel technology optimises the identification process of unknown molecules compared to mass analysis
Regulatory

4SC AG receives Paediatric Investigation Plan waiver for resminostat from the UK MHRA

The waiver allows the company to avoid investigating the CTCL drug in a paediatric population, as it's considered unnecessary or inappropriate for use by this patient group
Regulatory

The key role of IVDs in healthcare: challenges to commercialisation and access

In simple terms, in vitro diagnostic (IVD) tests are done on samples such as blood or tissue that have been taken from the human body. IVDs can detect diseases, conditions and infections, provide patients with a better understanding of their ailment and how it might be managed and changed with treatment
Regulatory

Post-Brexit border paperwork and inspections postponed for life sciences sector

The six month extension will allow life science companies to the make necessary alterations to their supply chains to accommodate for the novel post-Brexit border paperwork
Regulatory

Grifols Procleix ArboPlex arbovirus screening assay receives CE mark

The assay can detect four major arboviruses: chikungunya, dengue, West Nile and Zika
Regulatory

Innovating with purpose for safety and security of outcome

Beyond the importance of increasing productivity and generating more output and value with the same input, new ideas and technologies from GEA take innovation a step further
Subscribe now